The Mark Foundation For Cancer Research Us Ltd
EIN: 364825921 · New York, NY · NTEE: G30
| Metric | Value |
|---|---|
| Total Revenue | $48.5M |
| Total Expenses | $35.2M |
| Net Assets | $84.5M |
Is The Mark Foundation For Cancer Research Us Ltd Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About The Mark Foundation For Cancer Research Us Ltd
The Mark Foundation For Cancer Research Us Ltd (EIN: 364825921) is a nonprofit organization based in New York, NY, classified under NTEE code G30. The organization reported total revenue of $48.5M and total assets of $105.5M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of The Mark Foundation For Cancer Research Us Ltd's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
The Mark Foundation For Cancer Research Us Ltd is a large nonprofit that has been operating for 10 years, with 9 years of IRS 990 filings on record (2015–2023).
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $40.9M |
| Total Expenses | $35.2M |
| Surplus / Deficit | +$5.7M |
| Total Assets | $104.5M |
| Total Liabilities | $20.0M |
| Net Assets | $84.5M |
| Operating Margin | 14.0% |
| Debt-to-Asset Ratio | 19.2% |
| Months of Reserves | 35.6 months |
Financial Health Grade: A
In 2023, The Mark Foundation For Cancer Research Us Ltd reported a surplus of $5.7M with revenue exceeding expenses, holds 35.6 months of operating reserves (strong position), has a debt-to-asset ratio of 19.2% (very low leverage).
Financial Trends
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -26.0% | -7.4% | -5.6% |
| 2022 | +47.6% | +6.5% | +2.9% |
| 2021 | -6.7% | +64.9% | -1.3% |
| 2020 | -50.1% | -54.3% | +19.9% |
| 2019 | +98.8% | +22.9% | +168.8% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2016 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for The Mark Foundation For Cancer Research Us Ltd has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates The Mark Foundation For Cancer Research Us Ltd with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $5.7M, with revenue exceeding expenses.
- Debt-to-asset ratio: 19.2%.
Frequently Asked Questions about The Mark Foundation For Cancer Research Us Ltd
Is The Mark Foundation For Cancer Research Us Ltd a legitimate charity?
The Mark Foundation For Cancer Research Us Ltd (EIN: 364825921) is a registered tax-exempt nonprofit based in New York. It has 9 years of IRS 990 filings on record. Total revenue: $48.5M. No red flags identified. Financial health grade: A.
How does The Mark Foundation For Cancer Research Us Ltd spend its money?
The Mark Foundation For Cancer Research Us Ltd reported $48.5M in total revenue in IRS 990 filings. 9 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to The Mark Foundation For Cancer Research Us Ltd tax-deductible?
The Mark Foundation For Cancer Research Us Ltd is registered as a tax-exempt nonprofit (EIN: 364825921). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is The Mark Foundation For Cancer Research Us Ltd located?
The Mark Foundation For Cancer Research Us Ltd is headquartered in New York, New York and files with the IRS under EIN 364825921. It is classified under NTEE code G30.
How many years of IRS 990 filings does The Mark Foundation For Cancer Research Us Ltd have?
The Mark Foundation For Cancer Research Us Ltd has 9 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $48.5M in total revenue.
Filing History
IRS 990 filing history for The Mark Foundation For Cancer Research Us Ltd showing financial trends over 9 years of public records:
Total assets increased by 10449238700% over the same period, from $1 to $104.5M. In its most recent filing year (2023), The Mark Foundation For Cancer Research Us Ltd reported a surplus of $5.7M, with revenue exceeding expenses. The organization holds $20.0M in liabilities against $104.5M in assets (debt-to-asset ratio: 19.2%), resulting in net assets of $84.5M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $40.9M | $35.2M | $104.5M | $20.0M | — | — |
| 2022 | $55.3M | $38.0M | $110.7M | $28.1M | — | View 990 |
| 2021 | $37.5M | $35.7M | $107.6M | $38.1M | — | View 990 |
| 2020 | $40.2M | $21.6M | $109.0M | $43.5M | — | View 990 |
| 2019 | $80.5M | $47.3M | $90.9M | $47.4M | — | View 990 |
| 2018 | $40.5M | $38.5M | $33.8M | $23.9M | — | View 990 |
| 2017 | $10.6M | $5.4M | $8.1M | $2.8M | — | View 990 |
| 2016 | $500K | $291K | $296K | $87K | — | View 990 |
| 2015 | $0 | $0 | $1 | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $40.9M, expenses of $35.2M, and assets of $104.5M (revenue -26.0% year-over-year).
- 2022: Revenue of $55.3M, expenses of $38.0M, and assets of $110.7M (revenue +47.6% year-over-year).
- 2021: Revenue of $37.5M, expenses of $35.7M, and assets of $107.6M (revenue -6.7% year-over-year).
- 2020: Revenue of $40.2M, expenses of $21.6M, and assets of $109.0M (revenue -50.1% year-over-year).
- 2019: Revenue of $80.5M, expenses of $47.3M, and assets of $90.9M (revenue +98.8% year-over-year).
- 2018: Revenue of $40.5M, expenses of $38.5M, and assets of $33.8M (revenue +284.1% year-over-year).
- 2017: Revenue of $10.6M, expenses of $5.4M, and assets of $8.1M (revenue +2010.0% year-over-year).
- 2016: Revenue of $500K, expenses of $291K, and assets of $296K.
- 2015: Revenue of $0, expenses of $0, and assets of $1.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for The Mark Foundation For Cancer Research Us Ltd:
Data Sources and Methodology
This transparency report for The Mark Foundation For Cancer Research Us Ltd is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.